Spencer M. Moore

781 total citations
21 papers, 529 citations indexed

About

Spencer M. Moore is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Developmental Neuroscience. According to data from OpenAlex, Spencer M. Moore has authored 21 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Developmental Neuroscience. Recurrent topics in Spencer M. Moore's work include Multiple Sclerosis Research Studies (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and Retinal Development and Disorders (4 papers). Spencer M. Moore is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and Retinal Development and Disorders (4 papers). Spencer M. Moore collaborates with scholars based in United States, Israel and Canada. Spencer M. Moore's co-authors include Seema K. Tiwari‐Woodruff, Rhusheet Patel, Shalini Kumar, Anna J. Khalaj, Daniel K. Crawford, Daniel L. Chao, Mario Mangiardi, Sasidhar Venkata Manda, Dorota Skowronska‐Krawczyk and Norio Yasui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Scientific Reports.

In The Last Decade

Spencer M. Moore

21 papers receiving 526 citations

Peers

Countries citing papers authored by Spencer M. Moore

Since Specialization

Citations

This map shows the geographic impact of Spencer M. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer M. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer M. Moore more than expected).

Fields of papers citing papers by Spencer M. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer M. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer M. Moore. The network helps show where Spencer M. Moore may publish in the future.

Co-authorship network of co-authors of Spencer M. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer M. Moore. A scholar is included among the top collaborators of Spencer M. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer M. Moore. Spencer M. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptional reprogramming post-peripheral nerve injury: A systematic review 2024 ·Neurobiology of Disease ·Richard D. Hayward, Spencer M. Moore, (unknown), Ajay A. Madhavan, (unknown), (unknown), István Nagy	2
2	Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review 2023 ·Genes ·Spencer M. Moore, John Christoforidis	4
3	LONG-TERM OUTCOMES OF SUTURELESS INTRASCLERAL INTRAOCULAR LENS FIXATION IN CHILDREN AND ADULTS 2023 ·Retina ·Spencer M. Moore, (unknown), Mark K. Walsh	3
4	Rickettsia rickettsii infection as an unusual cause of pediatric retinitis: A case report 2022 ·American Journal of Ophthalmology Case Reports ·Spencer M. Moore, (unknown), (unknown)	3
5	Intraocular Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy: A Review 2022 ·Journal of VitreoRetinal Diseases ·(unknown), Spencer M. Moore, (unknown), John Christoforidis	16
6	Intravitreal Rituximab-Associated Retinal Occlusive Vasculitis 2022 ·Journal of VitreoRetinal Diseases ·(unknown), Spencer M. Moore, April E. Harris	2
7	Evaluating the neuroprotective impact of senolytic drugs on human vision 2020 ·Scientific Reports ·Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska‐Krawczyk, Sally L. Baxter	17
8	Targeting of the NRL Pathway as a Therapeutic Strategy to Treat Retinitis Pigmentosa 2020 ·Journal of Clinical Medicine ·Spencer M. Moore, Dorota Skowronska‐Krawczyk, Daniel L. Chao	20
9	Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice 2019 ·Translational Psychiatry ·Spencer M. Moore, Jason S. Seidman, Jacob Ellegood, Richard Gao, A. K. Savchenko, Ty D. Troutman, Yohei Abe, (unknown), Daehoon Lee, Sicong Wang, Bradley Voytek, Jason P. Lerch, Hoonkyo Suh, Christopher K. Glass, Alysson R. Muotri	25
10	Emerging Concepts for RNA Therapeutics for Inherited Retinal Disease 2019 ·Advances in experimental medicine and biology ·Spencer M. Moore, Dorota Skowronska‐Krawczyk, Daniel L. Chao	4
11	Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects 2016 ·The Journal of Steroid Biochemistry and Molecular Biology ·Anna J. Khalaj, Jonathan Hasselmann, (unknown), Spencer M. Moore, Seema K. Tiwari‐Woodruff	34
12	Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis 2014 ·Proceedings of the National Academy of Sciences ·Spencer M. Moore, Anna J. Khalaj, Shalini Kumar, (unknown), (unknown), (unknown), (unknown), Norio Yasui, John A. Katzenellenbogen, Seema K. Tiwari‐Woodruff	75
13	Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate 2014 ·Journal of Neuroscience Research ·Spencer M. Moore, Anna J. Khalaj, Rhusheet Patel, (unknown), (unknown), Liat Hayardeny, Seema K. Tiwari‐Woodruff	16
14	Therapeutic Laquinimod Treatment Restores Axon Myelination, Callosal Conduction and Motor Deficit in a Chronic Mouse Model of Multiple Sclerosis (P05.197) 2013 ·Neurology ·Spencer M. Moore, (unknown), (unknown), Rhusheet Patel, (unknown), Anna J. Khalaj, Seema K. Tiwari‐Woodruff	1
15	Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis 2013 ·Neurobiology of Disease ·Shalini Kumar, Rhusheet Patel, Spencer M. Moore, Daniel K. Crawford, (unknown), Mario Mangiardi, Seema K. Tiwari‐Woodruff	107
16	Sex chromosome complement influences functional callosal myelination 2013 ·Neuroscience ·Spencer M. Moore, Richa Patel, (unknown), Jie Yang, Seema K. Tiwari‐Woodruff	22
17	Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis 2013 ·Brain and Behavior ·Spencer M. Moore, Anna J. Khalaj, (unknown), Rhusheet Patel, (unknown), (unknown), Sasidhar Venkata Manda, (unknown), Liat Hayardeny, Seema K. Tiwari‐Woodruff	38
18	Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand 2013 ·Proceedings of the National Academy of Sciences ·Anna J. Khalaj, (unknown), (unknown), (unknown), Spencer M. Moore, (unknown), (unknown), Shalini Kumar, Noriko Itoh, Seema K. Tiwari‐Woodruff	64
19	Attenuation of Corpus Callosum Axon Myelination and Remyelination in the Absence of Circulating Sex Hormones 2013 ·Brain Pathology ·Rhusheet Patel, Spencer M. Moore, Daniel K. Crawford, (unknown), Sasidhar Venkata Manda, Kevin M. Tan, (unknown), Seema K. Tiwari‐Woodruff	60
20	Development of retinal vasculature in the frog Litoria moorei 1996 ·UWA Profiles and Research Repository (University of Western Australia) ·Sarah A. Dunlop, Spencer M. Moore, Matthew Tennant, Lyn Beazley	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact